Skip to content
Recall Observatory FDA recall evidence

Device product

Chembio DPP COVID-19 IgM/IgG System- Rrapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Model Number: 65-9569-0

Z-2807-2020

June 18, 2020

Class II

Product summary

Firm
Chembio Diagnostics, Inc
Event
Event 86098
Status
Terminated
Classification
Class II
Quantity
7,674 kits (153,480 devices)
Official record key
device-enforcement:Z-2807-2020

Official wording

Reason: FDA revocation of the Emergency Use Authorization due to performance issues

Code information: Lot Numbers: CV041020/A CV041520 CV040220/A1 CV042420 CV042920 CV040320/A2 CV050120

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    FDA revocation of the Emergency Use Authorization due to performance issues